10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $930 | -16.7% | 22,536 | +12.7% | 0.01% | -11.1% |
| Q2 2023 | $1,117 | +6.1% | 19,998 | +6.0% | 0.01% | 0.0% |
| Q1 2023 | $1,053 | +38.9% | 18,870 | -9.2% | 0.01% | +28.6% |
| Q4 2022 | $758 | -99.9% | 20,790 | +1.7% | 0.01% | +16.7% |
| Q3 2022 | $582,000 | -35.4% | 20,448 | +2.7% | 0.01% | -25.0% |
| Q2 2022 | $901,000 | -39.4% | 19,913 | +1.9% | 0.01% | -33.3% |
| Q1 2022 | $1,487,000 | -72.2% | 19,551 | -45.5% | 0.01% | -40.0% |
| Q4 2021 | $5,348,000 | +133.9% | 35,898 | +128.6% | 0.02% | +5.3% |
| Q3 2021 | $2,286,000 | -29.8% | 15,705 | -5.6% | 0.02% | -26.9% |
| Q2 2021 | $3,256,000 | +69.2% | 16,628 | +56.4% | 0.03% | -63.9% |
| Q1 2021 | $1,924,000 | +17.0% | 10,630 | -8.5% | 0.07% | +16.1% |
| Q4 2020 | $1,645,000 | +13.6% | 11,615 | -0.0% | 0.06% | -1.6% |
| Q3 2020 | $1,448,000 | +43.7% | 11,617 | +2.9% | 0.06% | +34.0% |
| Q2 2020 | $1,008,000 | – | 11,286 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |